Pre-existent immunity to the HER-2/neu oncogenic protein in patients with HER-2/neu overexpressing breast and ovarian cancer

Author： Disis M.L. Knutson K.L. Schiffman K. Rinn K. McNeel D.G.

Publisher： Springer Publishing Company

ISSN： 0167-6806

Source： Breast Cancer Research and Treatment, Vol.62, Iss.3, 2000-08, pp. : 245-252

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

HER-2/neu overexpression and in vitro chemosensitivity to CMF and FEC in primary breast cancer

By Konecny G.

Breast Cancer Research and Treatment, Vol. 69, Iss. 1, 2001-09 ,pp. : 53-63

Springer Publishing Company

Access to resources Recommend Favorite

Upregulation of HER-2/neu by Ovarian Ablation: Results of a Randomized Trial Comparing Leuprorelin to CMF as Adjuvant Therapy in Node-positive Breast Cancer Patients

By Lüftner D.

Breast Cancer Research and Treatment, Vol. 80, Iss. 3, 2003-08 ,pp. : 245-255

Springer Publishing Company

Access to resources Recommend Favorite

Anti-tumor immunity induced by an anti-idiotype antibody mimicking human Her-2/neu

By Mohanty Kartik Saha Asim Pal Smarajit Mallick Palash Chatterjee Sunil Foon Kenneth Bhattacharya-Chatterjee Malaya

Breast Cancer Research and Treatment, Vol. 104, Iss. 1, 2007-07 ,pp. : 1-11

Springer Publishing Company

Access to resources Recommend Favorite

Metaplastic breast carcinoma: clinical–pathologic characteristics and HER2/neu expression

By Barnes P.

Breast Cancer Research and Treatment, Vol. 91, Iss. 2, 2005-05 ,pp. : 173-178

Springer Publishing Company

Access to resources Recommend Favorite

Relevance of p185 HER-2/neu oncoprotein quantification in human primary breast carcinoma

By Bermont L.

Breast Cancer Research and Treatment, Vol. 63, Iss. 2, 2000-09 ,pp. : 163-169

Springer Publishing Company

Access to resources Recommend Favorite